Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Offenburg

22 clinical trials in Offenburg, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Offenburg at a glance
22
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

22 trials in Offenburg

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:University Of Cologne
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Epcoritamab
  • Sponsor:Universitaet Muenster
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:AGO Research GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:University Of Cologne
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Blinatumomab
  • Sponsor:Goethe University Frankfurt

Polyneuropathy

Recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Wala-Heilmittel GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:European Organisation For Research And Treatment Of Cancer
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cytarabine
  • Sponsor:Universitaetsklinikum Ulm AöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Epcoritamab
  • Sponsor:Universitaet Muenster
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Gilteritinib
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Offenburg

What the registry says about research in the country

01 Hematologic Oncology

Innovative clinical trials focusing on lymphomas and leukemias, including investigations of novel combination therapies for various B-cell lymphomas and advanced treatment approaches for acute myeloid leukemia.

  • Diffuse Large B-cell Lymphoma
  • Acute Myeloid Leukemia
  • Hodgkin Lymphoma

Research emphasizes personalized treatment strategies and targeted therapies for better patient outcomes.

02 Solid Tumor Research

Comprehensive studies examining treatments for various solid tumors, with particular emphasis on breast cancer and gastrointestinal malignancies.

  • Triple-Negative Breast Cancer
  • Colorectal Cancer
  • Gastroesophageal Cancer

Trials explore innovative combinations of immunotherapy and targeted treatments to improve survival rates.

03 Supportive Cancer Care

Studies focusing on managing treatment-related complications and improving quality of life for cancer patients, including research on chemotherapy-induced neuropathy.

  • Neuropathy Prevention
  • Treatment Optimization
  • Quality of Life Enhancement

Investigations aim to reduce treatment side effects and enhance patient comfort during therapy.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.